Trial intelligence / Profile preview

Sedatives for Intrahospital Transport of ICU Artificial Airway Patients

ChiCTR2100045851Phase 4Recruiting

Sponsor
The 2nd Affiliated Hospital of Harbin Medical University
Start
Apr 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in critical illness comparing Remimazolam group, Midazolam group and Propofol group (3 arms). Primary endpoint: percentage of target sedation time. Started Apr 2021; status: recruiting.

02

Drugs

remimazolammidazolampropofol
03

Conditions

critical illness

Beyond the preview

Go deeper on ChiCTR2100045851.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100045851.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call